Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial-Reference-Cited by-同舟云学术

Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

Published:2022-10 Issue:4 Volume:87 Page:815-824
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Blauvelt Andrew,Langley Richard G.,Lacour Jean-Philippe,Toth Darryl,Laquer Vivian,Beissert Stefan,Wollenberg Andreas,Herranz Pedro,Pink Andrew E.,Peris Ketty,Fangel Stine,Gjerum Le,Corriveau Joshua,Saeki Hidehisa,Warren Richard B.,Simpson Eric,Reich Kristian

Funder

Leo Pharma Research Foundation

Publisher

Elsevier BV

Subject

Dermatology

Reference16 articles.

1. Atopic dermatitis;Ständer;N Engl J Med,2021

2. Persistence of mild to moderate atopic dermatitis;Margolis;JAMA Dermatol,2014

3. Counting the burden: atopic dermatitis and health-related quality of life;Ali;Acta Derm Venereol,2020

4. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults;Ring;J Eur Acad Dermatol Venereol,2019

5. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children;Wollenberg;J Eur Acad Dermatol Venereol,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series;Anais Brasileiros de Dermatologia;2024-09

2. Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab;Dermatology Practical & Conceptual;2024-07-31

3. Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?;Journal of Personalized Medicine;2024-07-22

4. Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review;Dermatology and Therapy;2024-07-16

5. A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis;Journal of Clinical Medicine;2024-07-09